Workshop “16 years of Crystal16” – Dr. Olivier Monnier (Sanofi R&D)
Workshop “16 years of Crystal16” – Dr. Joop H. ter Horst (University of Strathclyde)
Workshop “16 years of Crystal16” – Dr. Ivan Marziano (Pfizer UK)
Parenteral Formulations
Co-crystals: a perspective on current practices
Stability of Protein Formulations and Their Importance
A Scientist’s Guide to Crystallisation Process Development
Multi Component Pharmaceuticals: From Solid Form Screening to Controlled Crystallisation
A Structured Impurity Rejection Approach In Industrial Crystallization Development
Influence of Polymers on Nucleation and Growth Kinetics of Pharmaceuticals
Crystallization Strategies the Quest for Increased Yield and Chiral Purity
Optimal Form Screening and Selection by Controlled Crystallization
Solvent Selection in Pharmaceutical Crystallisation Process Development
Revealing Shapes: Particle Morphology Hints Impurity Rejection Capability during API Crystallization
Linking Solution Chemistry to Crystallization
Viedma Ripening and Temperature Cycling: Two Robust Deracemization Methods
Accurate Measurement and Validation of Solubility Data for Polymorphic Compounds
Growing X-ray Quality Single Crystals
